Atlas Trials

A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy

Clinical trial NCT04857307 · COMPLETED

Trial details

NCT number
NCT04857307
Sponsor
UCB Biopharma SRL
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Epilepsy
Start date
2021-04-28
Primary completion
2022-04-05
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.